Avicanna’s subsidiary exports CBD and CBG into Paraguay
by CM Staff
The commercial export included Aureus branded purified Cannabidiol (CBD) and Cannabigerol (CBG) which is a part of the company’s portfolio of cannabinoid active pharmaceutical ingredients).
Avicanna’s subsidiary exports CBD and CBG into Paraguay
TORONTO — Avicanna Inc. a biopharmaceutical manufacturer of cannabis focused on the development and commercialisation of plant-derived cannabinoid-based products announces that through its majority owned subsidiary Santa Marta Golden Hemp the Company has completed the commercial export of aureus branded products into Paraguay.
The commercial export included Aureus branded purified Cannabidiol (CBD) and Cannabigerol (CBG) which is a part of the company’s portfolio of cannabinoid active pharmaceutical ingredients). This transaction also marks the 17th international market for Aureus branded products and 20th market for all Avicanna products which further demonstrates the company’s capabilities in navigating complex regulatory processes for its commercialization efforts internationally.
Avicanna’s supply chain business unit is based in Santa Marta, Colombia and provides a source of cannabinoid raw materials for the global marketplace with GACP and USDA organic ceritications. These include active pharmaceutical ingredients and feminized seeds, for Avicanna’s cosmetic, medical, and pharmaceutical products, in addition to supplying the company’s partners around the world.
